European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Microbiology and Infection

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1469-0691.12463PMID 24580738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.

  2014cited by this paper
• High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.

  2013cited by this paper
• First case of infection with vancomycin-resistant Staphylococcus aureus in Europe.

  2013cited by this paper
• The Impact of Linezolid versus Vancomycin on Surgical Interventions for Complicated Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus

  2013cited by this paper
• Fungal diagnosis: how do we do it and can we do better?

  2013cited by this paper
• Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus

  2013cited by this paper
• [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

  2013cited by this paper
• Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines.

  2013cited by this paper
• An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.

  2013cited by this paper
• Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus

  2013cited by this paper
• Comparison of Two Commercial PCR Methods for Methicillin-Resistant Staphylococcus aureus (MRSA) Screening in a Tertiary Care Hospital

  2012cited by this paper
• A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes

  2012influential reference
• Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study.

  2012cited by this paper
• Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.

  2012cited by this paper
• Antibiotic management and early discharge from hospital: an economic analysis.

  2012cited by this paper
• Dosing of antibiotics in obesity

  2012cited by this paper
• MRSA: the first half century.

  2012cited by this paper
• Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment

  2012cited by this paper
• Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections

  2012cited by this paper
• Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study

  2012cited by this paper
• Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management.

  2012cited by this paper
• Linezolid and Vancomycin in Treatment of Lower-Extremity Complicated Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus in Patients with and without Vascular Disease

  2012influential reference
• Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess.

  2012cited by this paper
• In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.

  2012cited by this paper
• Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.

  2012cited by this paper
• Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection.

  2012cited by this paper
• Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics.

  2012cited by this paper
• Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?

  2012cited by this paper
• Clinicians' knowledge, beliefs and acceptance of intravenous-to-oral antibiotic switching, Hospital Pulau Pinang.

  2012cited by this paper
• Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.

  2012cited by this paper
• Linezolid Surveillance Results for the United States: LEADER Surveillance Program 2011

  2012cited by this paper
• IDSA GUIDELINES Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children

  2011influential reference
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Patients' views and experience of intravenous and oral antimicrobial therapy: room for change.

  2011cited by this paper
• Inducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical Samples

  2011cited by this paper
• Treatment of MRSA soft tissue infections: an overview.

  2011influential reference
• LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States

  2011cited by this paper
• Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections in Hospitalized Patients

  2011influential reference
• Outcomes and management costs in patients hospitalized for skin and skin-structure infections.

  2011influential reference
• Frequency of Panton-Valentine Leukocidin-Producing Methicillin-Sensitive Staphylococcus Strains in Patients with Complicated Skin and Soft Tissue Infection in Bronx, New York

  2011cited by this paper
• Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries

  2011cited by this paper
• Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan

  2011cited by this paper
• Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review

  2011cited by this paper
• Diagnosis and management of Skin and Soft-Tissue Infections (SSTI): a Literature Review and Consensus Statement on Behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy

  2011influential reference
• New Gram-positive antibiotics: better than vancomycin?

  2011cited by this paper
• Methicillin-resistant Staphylococcus aureus: the European landscape.

  2011cited by this paper
• Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.

  2011cited by this paper
• Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.

  2011cited by this paper
• Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging?

  2011cited by this paper
• Skin and Soft Tissue Infections: The New Surgical Infection Society Guidelines

  2011cited by this paper
• Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.

  2010influential reference
• Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

  2010influential reference
• Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.

  2010cited by this paper
• Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

  2010cited by this paper
• Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.

  2010influential reference
• Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe.

  2010cited by this paper
• Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes.

  2010influential reference
• Risk stratification and outcome of cellulitis admitted to hospital.

  2010cited by this paper
• CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

  2010cited by this paper
• Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.

  2010cited by this paper
• The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid

  2010cited by this paper
• The treatment of diabetic foot infections.

  2010cited by this paper
• Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.

  2010influential reference
• MRSA: treating people with infection.

  2010cited by this paper
• Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.

  2010influential reference
• Complicated skin and soft tissue infection.

  2010influential reference
• CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

  2010cited by this paper
• Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?

  2010cited by this paper
• Diabetes and Peripheral Vascular Disease

  2009cited by this paper
• Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors

  2009influential reference
• Severe soft tissue infections.

  2009cited by this paper
• Outcomes of early switching from intravenous to oral antibiotics on medical wards

  2009cited by this paper
• Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics

  2009cited by this paper
• Evaluating Aztreonam and Ceftazidime Pharmacodynamics with Escherichia coli in Combination with Daptomycin, Linezolid, or Vancomycin in an In Vitro Pharmacodynamic Model

  2009cited by this paper
• Methicillin-resistant Staphylococcus aureus in orthopaedic trauma: identification of risk factors as a strategy for control of infection.

  2009cited by this paper
• Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.

  2009cited by this paper
• Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

  2009cited by this paper
• Cutaneous mucormycosis: report of five cases and review of the literature.

  2009cited by this paper
• Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.

  2009cited by this paper
• Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.

  2009cited by this paper
• Sporotrichoid Aspergillosis in an Immunocompromised Child: A Case Report and Review of the Literature

  2009cited by this paper
• Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.

  2009cited by this paper
• Skin and soft tissue infection: microbiology and epidemiology.

  2009cited by this paper
• The Graying of Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Surgical Site Infections: Does Inadequate Antibiotic Therapy Affect Patient Outcomes?

  2009cited by this paper
• A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial.

  2009cited by this paper
• Bacterial Skin and Soft Tissue Infections

  2009influential reference
• An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit.

  2008cited by this paper
• Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England.

  2008cited by this paper
• Fatores de risco que afetam as complicações da dissecação da veia safena na revascularização cirúrgica do miocárdio

  2008cited by this paper
• How complicated skin and soft tissue infections are treated in Italy: economic evaluation of inpatient intravenous antibiotic treatment in seven hospitals

  2008cited by this paper
• Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure Infections

  2008influential reference
• Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.

  2008cited by this paper
• The risk factors affecting the complications of saphenous vein graft harvesting in aortocoronary bypass surgery.

  2008cited by this paper
• Vascular surgical site infection: risk factors and preventive measures.

  2008cited by this paper
• Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.

  2008influential reference
• Risk Factors for Methicillin-Resistant Staphylococcus aureus Surgical Site Infection

  2008cited by this paper
• Primary cutaneous aspergillosis in a patient with a solid organ transplant: case report and review of the literature.

  2008cited by this paper
• National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.

  2008cited by this paper
• Increasing Hospitalizations and General Practice Prescriptions for Community-onset Staphylococcal Disease, England

  2008cited by this paper

• Dual role of Baimao-Longdan-Congrong-Fang in inhibiting Staphylococcus aureus virulence factors and regulating TNF-α/TNFR1/NF-κB/MMP9 axis.

  2025cites this paper
• Predictors of sepsis, intensive care unit admission, and death in patients hospitalized for complicated skin and soft tissue infections: Retrospective study at a large tertiary-care center

  2025cites this paper
• Clinical use and safety profile of intravenous linezolid in hospitalised children: A retrospective cohort experience

  2025influential citation
• Identification of Staphylococcus aureus Causing Contamination in Raw Beef and Meat-Processing Environments in Ulaanbaatar, Mongolia

  2025cites this paper
• Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Characterization and complete genome sequence of highly lytic phage active against methicillin-resistant Staphylococcus aureus (MRSA) isolated from Egypt

  2024cites this paper
• Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients

  2024cites this paper
• Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study

  2024cites this paper
• Linezolid Loaded Nanoparticle for Topical Administration of Diabetic Foot Treatment: Formulation, In Vitro and Ex Vivo Characterization

  2024cites this paper
• Cinnamaldehyde targets SarA to enhance β‐lactam antibiotic activity against methicillin‐resistant Staphylococcus aureus

  2024cites this paper
• GHK-Cu/Pionin-loaded in situ electrospun PVB/PVP smart dressing promotes wound healing via anti-oxidant, anti-inflammatory, antimicrobial, and tissue regenerative effects

  2024cites this paper
• Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections

  2023cites this paper
• Liposome-loaded polymeric microneedles for enhanced skin deposition of rifampicin.

  2023cites this paper
• In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020

  2023cites this paper
• State-of-the-Art of Synthesized Exosomes and NPs-Based Biomimetic Nanoparticles for Wound Rehabilitation: A Review

  2023cites this paper
• Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT)

  2023cites this paper
• Characterization of pediatric patients with necrotizing pneumonia treated at a quaternary care center in Bogotá, Colombia, 2010-2017

  2023cites this paper
• First detection of tet(X4)-positive Enterobacterales in retail vegetables and clonal spread of Escherichia coli ST195 producing Tet(X4) in animals, foods, and humans across China and Thailand.

  2023cites this paper
• Antimicrobial Activity of Cellulose Based Materials

  2022cites this paper
• Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?

  2022cites this paper
• Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections

  2022cites this paper
• The Synergistic Effect between Antibiotics and Biosynthesized ZnO Nanoparticles The effect of ZnO

  2022cites this paper
• Evaluating linezolid dose regimens against methicillin‐resistant Staphylococcus aureus based on renal function in populations with different body weight

  2022cites this paper
• Multidisciplinary panel opinion on the management of bacterial skin infections

  2022cites this paper
• Distinctions between Fournier's Gangrene and Lower Extremity Necrotising Fasciitis: Microbiology and Factors Affecting Mortality.

  2022cites this paper
• Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence

  2022cites this paper
• Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections

  2022cites this paper
• Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System

  2022cites this paper
• Antibiotic treatment of acute bacterial skin and skin structure infections

  2022cites this paper
• Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan

  2022cites this paper
• Potential Clinical Benefits of TDM of Antimicrobials in Japan

  2022cites this paper
• Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials

  2021cites this paper
• A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model

  2021cites this paper
• Bacterial Skin and Soft Tissue Infections in Children

  2021cites this paper
• Photodynamic Therapy Combined with Antibiotics or Antifungals against Microorganisms That Cause Skin and Soft Tissue Infections: A Planktonic and Biofilm Approach to Overcome Resistances

  2021cites this paper
• Antimicrobial Management of Complicated Skin and Soft Tissue Infections in an Era of Emerging Multi-Drug Resistance: Perspectives from 5 Gulf Countries

  2021cites this paper
• Methicillin-resistant Staphylococcus aureus (MRSA) submandibular abscess in a neonate

  2021cites this paper
• Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR)

  2021cites this paper
• Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates.

  2020cites this paper
• Complicated Posterior Cervical Skin and Soft Tissue Infections at a Single Referral Center

  2020cites this paper
• Identification bioactive compounds from marine microorganism and exploration of structure–activity relationships (SARs)

  2020cites this paper
• A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

  2020cites this paper
• Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection

  2020cites this paper
• Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials

  2020cites this paper
• Spotlight on New Antibiotics for the Treatment of Pneumonia

  2020cites this paper
• Chronic wounds: treatments and relevant educational strategies

  2020cites this paper
• Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study

  2020cites this paper
• Bacterial Skin Abscess

  2020cites this paper
• Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group

  2019cites this paper
• Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection

  2019cites this paper
• Skin and soft tissue infections after breast surgery

  2019cites this paper
• Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection

  2019cites this paper
• The safety of treatment options for acute bacterial skin and skin structure infections

  2019cites this paper
• Etiology, characteristics, and outcomes of community-onset necrotizing fasciitis in Korea: A multicenter study

  2019cites this paper
• CE_A_187499 31..40

  2019cites this paper
• Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy

  2019cites this paper
• Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis

  2019cites this paper
• Emerging drugs for treating methicillin-resistant Staphylococcus aureus

  2019cites this paper
• Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys

  2019cites this paper
• Prescription of antibiotics in infections of the skin and soft tissues

  2018influential citation
• Discovery of antimicrobial compounds from Lendenfeldia, Ircinia and Dysidea sponges using bioassay guided fractionation of marine extracts

  2018cites this paper
• Management of bacterial skin and skin structure infections with polymicrobial etiology

  2018cites this paper
• Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

  2018influential citation
• New Antibiotics for Pneumonia.

  2018cites this paper
• Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

  2018cites this paper
• A New Kind of Quinonic-Antibiotic Useful Against Multidrug-Resistant S. aureus and E. faecium Infections

  2018cites this paper
• Managing pulmonary embolism secondary to suppurative deep vein thrombophlebitis due to community-acquired Staphylococcus aureus in a resource-poor setting

  2018cites this paper
• The what, when and how in performing and interpreting microbiological diagnostic tests in skin and soft tissue infections

  2018cites this paper
• Dalbavancin in the treatment of skin and soft tissue infections

  2018cites this paper
• In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.

  2018cites this paper
• Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections

  2018cites this paper
• When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections

  2018cites this paper
• An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.

  2018cites this paper
• Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012–2017

  2018cites this paper
• A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus

  2017cites this paper
• The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection

  2017cites this paper
• Características clínicas y microbiológicas de las infecciones de piel y tejidos blandos por Staphylococcus aureus en niños de un hospital en Medellín durante los años 2013 a 2015

  2017cites this paper
• Mise au point sur l’antibiothérapie des infections bactériennes de la peau et des tissus mous en France

  2017cites this paper
• Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update

  2017cites this paper
• The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections

  2017cites this paper
• Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure

  2017cites this paper
• Linezolid-related adverse effects in clinical practice in children.

  2017cites this paper
• Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes

  2017cites this paper
• Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment.

  2016cites this paper
• Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.

  2016cites this paper
• Hot topics in the diagnosis and management of skin and soft-tissue infections.

  2016cites this paper
• Staphylococcus aureus-Associated Skin and Soft Tissue Infections: Anatomical Localization, Epidemiology, Therapy and Potential Prophylaxis.

  2016cites this paper
• Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe.

  2016cites this paper
• Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

  2016influential citation
• Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.

  2016influential citation
• Skin and soft tissue infections and acute kidney injury: a systematic review

  2016cites this paper
• Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.

  2016cites this paper
• Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013

  2016cites this paper
• Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections

  2016cites this paper
• Pharmacokinetics of linezolid in critically ill patients

  2016cites this paper
• Advances in the medical management of skin and soft tissue infections

  2016cites this paper
• Molecular Epidemiology of Staphylococcus aureus among Patients with Skin and Soft Tissue Infections in Two Chinese Hospitals

  2016cites this paper
• Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)

  2015cites this paper
• Synthesis and antibiotic activity of oxazolidinone-catechol conjugates against Pseudomonas aeruginosa.

  2015cites this paper
• Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey.

  2015cites this paper